BTAI — BioXcel Therapeutics Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.81 Analyst target: $14.00 Upside: 1632.67%

See the full interactive analysis & chart →

Informational only — not investment advice.